Please use this identifier to cite or link to this item: https://doi.org/10.1038/s41586-019-1795-x
Title: Structure and drug resistance of the Plasmodium falciparum transporter PfCRT
Authors: Kim, Jonathan
Tan, Yong Zi 
Wicht, Kathryn J
Erramilli, Satchal K
Dhingra, Satish K
Okombo, John
Vendome, Jeremie
Hagenah, Laura M
Giacometti, Sabrina I
Warren, Audrey L
Nosol, Kamil
Roepe, Paul D
Potter, Clinton S
Carragher, Bridget
Kossiakoff, Anthony A
Quick, Matthias
Fidock, David A
Mancia, Filippo
Keywords: Science & Technology
Multidisciplinary Sciences
Science & Technology - Other Topics
CHLOROQUINE RESISTANCE
CRYO-EM
SYNTHETIC ANTIBODIES
MEMBRANE-PROTEINS
MALARIA PARASITES
PHAGE DISPLAY
MECHANISM
ORIENTATION
VALIDATION
METABOLISM
Issue Date: 12-Dec-2019
Publisher: NATURE PUBLISHING GROUP
Citation: Kim, Jonathan, Tan, Yong Zi, Wicht, Kathryn J, Erramilli, Satchal K, Dhingra, Satish K, Okombo, John, Vendome, Jeremie, Hagenah, Laura M, Giacometti, Sabrina I, Warren, Audrey L, Nosol, Kamil, Roepe, Paul D, Potter, Clinton S, Carragher, Bridget, Kossiakoff, Anthony A, Quick, Matthias, Fidock, David A, Mancia, Filippo (2019-12-12). Structure and drug resistance of the Plasmodium falciparum transporter PfCRT. NATURE 576 (7786) : 315-+. ScholarBank@NUS Repository. https://doi.org/10.1038/s41586-019-1795-x
Abstract: The emergence and spread of drug-resistant Plasmodium falciparum impedes global efforts to control and eliminate malaria. For decades, treatment of malaria has relied on chloroquine (CQ), a safe and affordable 4-aminoquinoline that was highly effective against intra-erythrocytic asexual blood-stage parasites, until resistance arose in Southeast Asia and South America and spread worldwide1. Clinical resistance to the chemically related current first-line combination drug piperaquine (PPQ) has now emerged regionally, reducing its efficacy2. Resistance to CQ and PPQ has been associated with distinct sets of point mutations in the P. falciparum CQ-resistance transporter PfCRT, a 49-kDa member of the drug/metabolite transporter superfamily that traverses the membrane of the acidic digestive vacuole of the parasite3–9. Here we present the structure, at 3.2 Å resolution, of the PfCRT isoform of CQ-resistant, PPQ-sensitive South American 7G8 parasites, using single-particle cryo-electron microscopy and antigen-binding fragment technology. Mutations that contribute to CQ and PPQ resistance localize primarily to moderately conserved sites on distinct helices that line a central negatively charged cavity, indicating that this cavity is the principal site of interaction with the positively charged CQ and PPQ. Binding and transport studies reveal that the 7G8 isoform binds both drugs with comparable affinities, and that these drugs are mutually competitive. The 7G8 isoform transports CQ in a membrane potential- and pH-dependent manner, consistent with an active efflux mechanism that drives CQ resistance5, but does not transport PPQ. Functional studies on the newly emerging PfCRT F145I and C350R mutations, associated with decreased PPQ susceptibility in Asia and South America, respectively6,9, reveal their ability to mediate PPQ transport in 7G8 variant proteins and to confer resistance in gene-edited parasites. Structural, functional and in silico analyses suggest that distinct mechanistic features mediate the resistance to CQ and PPQ in PfCRT variants. These data provide atomic-level insights into the molecular mechanism of this key mediator of antimalarial treatment failures.
Source Title: NATURE
URI: https://scholarbank.nus.edu.sg/handle/10635/227205
ISSN: 00280836
14764687
DOI: 10.1038/s41586-019-1795-x
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
2019-11-27_Kim_Nature.pdfPublished version17.49 MBAdobe PDF

CLOSED

None

SCOPUSTM   
Citations

66
checked on Oct 1, 2022

Page view(s)

28
checked on Sep 29, 2022

Download(s)

1
checked on Sep 29, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.